| 155 | 3 | 572 |
| 下载次数 | 被引频次 | 阅读次数 |
目的对我院抗幽门螺杆菌的门诊处方进行调查分析,为临床合理用药提供参考。方法利用医院信息系统调取我院2015年门诊抗幽门螺杆菌处方共1 019张,分析抗幽门螺杆菌药物的使用情况。结果铋剂四联疗法临床使用最多,其中铋剂+标准三联方案占36.11%,单张处方金额平均为262.76元,多为7 d疗程。抗菌药物中使用率最高的为克拉霉素缓释片,质子泵抑制剂中使用率最高的为雷贝拉唑胶囊,抗酸及胃黏膜保护药中使用率最高的为胶体果胶铋胶囊。结论抗幽门螺杆菌临床治疗方案众多且在不断改进,我院门诊处方在疗程、药品选择等方面有待进一步完善。
Abstract：AIM To investigate and analyze the prescriptions for anti-H. pylori in outpatient department and provide reference for rational use of drug. METHODS Using a pharmacy administration software,the prescriptions for anti-H. pylori in outpatient department in 2015 was reviewed,the pattern of clinical use of anti-H.pylori was investigated. RESULTS Bismuth quadruple therapy was used most,standard triple therapy combined with bismuth was 36. 11%,262. 76 yuan for the average amount of prescription and for 7 d course of treatment normally; the highest rate of antibacterial drugs was clarithromycin sustained tablets,the highest rate of proton pump inhibitor was rabeprazole capsules,and the highest rate of antacid and gastric mucosal protectant was colloidal bismuth pectin capsules. CONCLUSION The clinical projects of treatment for anti-H. pylori are numerous and ever-improving,and the prescriptions in outpatient department can be improved in the course of treatment,and the choices of drugs,etc.
[1]中华医学会消化病学分会幽门螺杆菌学组/全国幽门螺杆菌研究协作组,刘文忠,谢勇,等.第四次全国幽门螺杆菌感染处理共识报告[J].中华消化杂志,2012,32(10):655.
[2]FOCK KM,KATELARIS P,SUGANO K,et al.Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection[J].J Gastroenterol Hepatol,2009,24(10):1587.
[3]MALFERTHEINER P,MEGRAUD F,O'MORAIN CA,et al.Management of Helicobacter pylori infection-the MaastrichtⅣ/florence consensus report[J].Gut,2012,61:646.
[4]SUN Q,LIANG X,ZHENG Q,et a L.High efficacy of 14-day triple therapy-based,bismuth-containing quadruple therapy for initial Helicobacter pylori eradication[J].Helicobacter,2010,15(3):233.
[5]成虹,胡伏莲,谢勇,等.中华医学会消化病分会幽门螺杆菌学组/全国幽门螺杆菌科研协作组.中国幽门螺杆菌耐药状况以及耐药对治疗的影响-全国多中心临床研究[J].胃肠病学,2007,12(9):525.
[6]李云振,胡伟鹏,高宏志,等.幽门螺杆菌抗生素耐药机制研究进展[J].微生物学通报,2014,41(5):983.
[7]张鑫,刘正新,李亚强,等.幽门螺杆菌根除疗效与CYP2C19基因多态性的相关性分析研究[J].中国医刊,2014,49(2):132.
[8]吴明慧,黄赞松,黄衍强.幽门螺杆菌外排泵的研究进展[J].世界华人消化杂志,2013,21(17):1630.
[9]崔梅花,魏红,雷晓燕,等.含复方尿囊素四联疗法治疗幽门螺杆菌感染慢性胃炎的疗效[J].中华消化杂志,2014,34(5):297.
[10]杨勇,曹官铭,杨晓娟.铝碳酸镁联合标准三联疗法根除幽门螺杆菌效果分析[J].西南国防医药,2015,25(6):595.
[11]关瑞云,廖朝峰.铝镁加混悬液联用埃索美拉唑治疗幽门螺杆菌阳性十二指肠溃疡的疗效观察[J].国际医药卫生导报,2014,20(14):2134.
[12]胡伏莲.幽门螺杆菌根除失败的原因分析和处理策略[J].现代消化及介入诊疗,2010,15(2):108.
[13]卫金岐,农高惠,陈美竹,等.广东珠海地区幽门螺杆菌对常用抗菌药物的体外耐药情况[J].中国临床药学杂志,2013,22(4):234.
[14]成虹,胡伏莲,张国新,等.含左氧氟沙星三联疗法一线治疗幽门螺杆菌感染:多中心随机对照临床研究[J].中华医学杂志,2010,90(2):79.
基本信息:
DOI：10.19577/j.cnki.issn10074406.2017.01.010
中图分类号:R95
引用信息:
[1]邵燕,刘群,张东萍,等.我院2015年门诊抗幽门螺杆菌处方分析[J].中国临床药学杂志,2017,26(01):39-42.DOI:10.19577/j.cnki.issn10074406.2017.01.010.
2016-02-23
2016
2016-11-07
2016
1
2017-01-25
2017-01-25